Shopping Cart
Remove All
Your shopping cart is currently empty
BRD-8000.3 is a narrow-spectrum, bactericidal antimycobacterial agent that specifically inhibits EfpA,specifically designed to kill drug-tolerant Mtb.Study revealed BRD-8000.3 at resolutions of 2.9 Å and 3.4 Å, resp, EfpA forms an antiparallel dimer. Functional studies reveal that EfpA is a lipid transporter and BRD-8000.3 inhibits its lipid transport activity.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 25 mg | $1,520 | 6-8 weeks | 6-8 weeks | |
| 50 mg | $1,980 | 6-8 weeks | 6-8 weeks | |
| 100 mg | $2,500 | 6-8 weeks | 6-8 weeks |
| Description | BRD-8000.3 is a narrow-spectrum, bactericidal antimycobacterial agent that specifically inhibits EfpA,specifically designed to kill drug-tolerant Mtb.Study revealed BRD-8000.3 at resolutions of 2.9 Å and 3.4 Å, resp, EfpA forms an antiparallel dimer. Functional studies reveal that EfpA is a lipid transporter and BRD-8000.3 inhibits its lipid transport activity. |
| In vitro | BRD-8000.3 is a specific EfpA inhibitor of Parazacco spilurus subsp. spilurus, belonging to the narrow-spectrum bactericidal antimycobacterial drugs, exhibiting good activity against wild-type strains [1]. |
| Synonyms | BRD8000.3 |
| Molecular Weight | 401.3 |
| Formula | C19H21BrN4O |
| Cas No. | 2365504-95-4 |
| Smiles | C(NC=1N=C(Br)C(=CC1)C=2N=CC=CN2)(=O)[C@H]3[C@H](C=C(C)C)C3(C)C |
| Relative Density. | 1.415 g/cm3 (Predicted) |
| Color | White |
| Appearance | Solid |
| Storage | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 40 mg/mL (99.68 mM), Sonication is recommended. | ||||||||||||||||||||||||||||||
| In Vivo Formulation | 10% DMSO+90% Corn Oil: 2 mg/mL (4.98 mM), Sonication is recommeded. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. | ||||||||||||||||||||||||||||||
Solution Preparation Table | |||||||||||||||||||||||||||||||
DMSO
| |||||||||||||||||||||||||||||||
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.